高敏C反应蛋白与腹主动脉瘤腔内修复术后瘤囊缩小的关联
本研究纳入2013年11月至2019年4月在一所大学医院使用Gore C3 Excluder行EVAR的143例患者,比较术前与术后CT的瘤囊直径变化。术后1年瘤囊缩小(≥5 mm)48例(34%),多因素分析显示术前hsCRP>0.19 mg/dL(OR=0.22;95%CI 0.05-0.96;p=0.042)与肾囊肿存在(OR=0.31;95%CI 0.15-0.67;p=0.002)是瘤囊缩小的独立危险因素。
要点
- 术后1年瘤囊缩小(≥5 mm)48例(34%),稳定93例(65%),增大2例(1.4%)。
- 术前hsCRP>0.19 mg/dL与瘤囊缩小独立相关(OR=0.22;95%CI 0.05-0.96;p=0.042)。
- 肾囊肿存在与瘤囊缩小独立相关(OR=0.31;95%CI 0.15-0.67;p=0.002)。
核心结论
- 腹主动脉瘤患者EVAR术后,术前hsCRP水平与瘤囊缩小独立相关。
- 作者认为高hsCRP水平可能是EVAR术后瘤囊缩小的阴性预测因素。
研究设计与样本
- 2013年11月至2019年4月在一所大学医院纳入143例使用Gore C3 Excluder行EVAR的患者。
- 比较术前基线CT与术后CT的瘤囊直径,瘤囊直径变化≥5 mm视为显著(增大或缩小)。
主要发现
- 瘤囊直径从术前50.6±9.8 mm降至术后1年47.1±10.3 mm。
- 术后1年瘤囊缩小(≥5 mm)48例(34%),瘤囊稳定93例(65%),瘤囊增大2例(1.4%)。
- 术前hsCRP均值0.33±0.54 mg/dL。
- 单因素分析显示术前hsCRP(p=0.029)和肾囊肿存在(p=0.002)与瘤囊缩小相关。
- 多因素分析显示术前hsCRP>0.19 mg/dL(OR=0.22;95%CI 0.05-0.96;p=0.042)和肾囊肿存在(OR=0.31;95%CI 0.15-0.67;p=0.002)是瘤囊缩小的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The factors associated with aneurysm sac shrinkage after endovascular aneurysm repair (EVAR) are not well established. As inflammation is implicated in aneurysm pathophysiology, we hypothesized that high-sensitivity C-reactive protein (hsCRP) was associated with aneurysm sac shrinkage after EVAR and compared the preoperative level of hsCRP between patients with and without postoperative aneurysm sac shrinkage after EVAR. METHODS: From November 2013 to April 2019, 143 patients undergoing EVAR using Gore C3 Excluder (W. L. Gore & Associates, Inc, Flagstaff, Arizona) at our university hospital were included in this study. Aneurysm sac size was compared between that on baseline preoperative computed tomography (CT) and that on postoperative CT scans. A change in aneurysm sac size ≥5 mm was considered to be significant, whether due to enlargement or shrinkage. RESULTS: Aneurysm sac size showed a significant decrease from 50.6 ± 9.8 mm to 47.1 ± 10.3 mm at 1 year. At 1 year postoperatively, aneurysm sac shrinkage (≥5 mm) was observed in 48 patients (34%), a stable aneurysm sac was noted in 93 patients (65%), and aneurysm sac enlargement was noted in 2 patients (1.4%). The mean preoperative hsCRP was 0.33 ± 0.54 mg/dL. Univariable analysis showed that preoperative hsCRP (p=0.029) and the presence of a renal cyst (p=0.002) were associated with aneurysm sac shrinkage. Multivariable analysis showed that preoperative hsCRP [>0.19mg/dL] (odds ratio [OR] = 0.22; 95% confidence interval [CI] = 0.05-0.96; p=0.042), and the presence of a renal cyst (OR = 0.31; 95% CI = 0.15-0.67; p=0.002) were independent risk factors for aneurysm sac shrinkage after EVAR. CONCLUSIONS: The level of preoperative hsCRP was independently associated with aneurysm sac shrinkage after EVAR in patients with abdominal aortic aneurysms. These data suggest that the high level of hsCRP can be a negative predictor for aneurysm sac shrinkage after EVAR.
引用
- Kano M, Nishibe T, Dardik A, et al. Association of High-Sensitivity C-Reactive Protein With Aneurysm Sac Shrinkage in Patients Undergoing Endovascular Abdominal Aneurysm Repair. J Endovasc Ther. 2021. PMID: 34969319. doi:10.1177/15266028211067738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。